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Background: Ocular lesions in patients on highly active antiretroviral therapy (HAART) have shown changes in
disease prevalence and pattern. Although they have been described in the Western population, there are not many
such studies in the HAART era from India. This study aims to present the clinical profile, systemic correlation, and
visual outcome in HIV-positive patients in relation to HAART in comparison with pre-HAART Indian studies and
current Western data. Ocular findings and systemic correlation in 1,000 consecutive patients with HIV seen at a
tertiary eye care center were analyzed. This study uses a prospective observational case series design.
Results: Age range of the patients was 1.5 to 75 years. Ocular lesions were seen in 68.5% of the patients
(cytomegalovirus (CMV) retinitis was the commonest). The commonest systemic disease was pulmonary TB. Mean
interval between HIV diagnosis and onset of ocular lesions was 2.43 years. CD4 counts range from 2 to 1,110 cells/
mm3. Immune recovery uveitis (IRU) was seen in 17.4%. Interval between HAART initiation and IRU was 4 months to
2.5 years. Recurrence of ocular infection was seen in 2.53% (post-HAART) and > 20% (pre-HAART). Overall visual
outcome showed improvement in about 14.3% and was maintained in 71.6% of the patients.
Conclusions: CMV retinitis is the commonest ocular opportunistic infection in India, even in the HAART era. Newer
manifestations of known diseases and newer ocular lesions are being seen. In contrast to Western studies, in our
patients on HAART, ocular lesions do not always behave as in immunocompetent individuals. Ocular TB needs to
be kept in mind in India, as well as other neuro-ophthalmic manifestations related to cryptococci, especially in
gravely ill patients. Occurrence and frequency of various ocular opportunistic infections in developing nations
such as India have significant variations from those reported in Western literature and need to be managed
accordingly.
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Ocular lesions attributable to HIV [1] are seen in upto 2/
3rd of the estimated 2.5 million HIV-positive population
[2] in India at some point in their lifetime.
Ocular lesions in patients on highly active antiretroviral
therapy (HAART) have shown changes in disease preva-
lence and pattern and have been described in the Western
population. Ocular lesions associated with AIDS in India
have been described in the past during the pre-HAART era
[3-9]. There are not many long-term studies on ocular
lesions of HIV-positive patients in relation to HAART,* Correspondence: drdharshan@gmail.com
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reproduction in any medium, provided the origespecially in developing nations such as India. We studied
the ocular lesions and systemic correlation of 1,000 con-
secutive patients with HIV in India especially with respect
to HAART in comparison with pre-HAART Indian studies
and current Western data.
Results
One thousand HIV-positive patients were included in
the study. Their age ranged between 18 months to
75 years (median age, 35 years). Male-to-female ratio
was 7:3. The most common presenting complaints were
decreased vision and floaters. Overall, ocular lesions at-
tributable to HIV/AIDS were found in 68.5% of the
patients (Table 1). Interval between diagnosis of HIV
and onset of ocular lesions ranged from 10 days tois is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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ARN, acute retinal necrosis; CMV, cytomegalovirus; SJ syndrome, Steven-
Johnson syndrome.
Table 2 Underlying systemic disease associations in
patients with HIV








Table 3 Ocular lesions in correlation with systemic
disease




(n (%)) (n (%))
CMVR (n = 248) 164 (66.13) 84 (33.87)
HIV retinopathy (n = 43) 28 (65.12) 15 (34.88)
Ocular TB (n = 26) 17 (65.38) 9 (34.62)
Toxoplasmosis (n = 28) 17 (60.71) 11 (39.29)
HZO (n = 22) 18 (81.82) 4 (18.18)
Others (n = 318) 142 (44.85) 176 (55.3)
CMVR, cytomegalovirus retinitis; HZO, herpes zoster ophthalmicus.
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to 1,110 cells/mm3 (mean 270.82 + 213.36, median
224.50) at the time of inclusion into the study. Mean
follow-up was 67 months (range between 1 month and
11 years), and median duration of HIV disease was
360 days. More than 65% of the patients had at least 1 year
follow-up. About 51.3% of the patients had an underlying
systemic disease. Systemic tuberculosis, the most common
opportunistic systemic infection in our study, was seen in
43%, of which pulmonary tuberculosis was seen in 38.01%
of patients (Table 2). Other systemic diseases included
Cryptococcus infection, pneumonia, central nervous sys-
tem (CNS) toxoplasmosis, and others. Out of 48.70%
without any underlying systemic disease, 74.74% were
without ocular lesions, while 25.26% had ocular lesions at-
tributable to HIV (Table 3).
Among patients with ocular lesions, CMV retinitis
(Figure 1) was the commonest and was seen in 248
patients (36.2%). All patients with active CMV retinitiswere treated with induction therapy with intravenous gan-
ciclovir (5 mg/kg of body weight every 12 h) along with an
intravitreal injection of ganciclovir, in most cases followed
by maintenance therapy. In our study, two patients with
CMV retinitis on HAART presented with neovasculariza-
tion and vitreous and subretinal hemorrhage and were
managed accordingly.
Ocular toxoplasmosis (Figure 2) was the next most
common ocular opportunistic infection and was seen in
28 patients (4.09%). Most of them were diagnosed based
on clinical features and supportive anterior chamber tap
findings, positive polymerase chain reaction (PCR) or
antibodies for toxoplasmosis. All patients were treated
with combined anti-toxoplasma therapy based on clin-
ical and serological evidence.
Ocular tuberculosis (Figure 3) was seen in 26 patients
(3.8% patients), presenting as choroidal tubercles, subret-
inal abscess, conjunctival tuberculosis, and panophthalmi-
tis. All cases had evidence of pulmonary tuberculosis.
Coexistent central nervous system and abdominal tuber-
culosis were the associations. CD4+ cell counts in patients
with ocular tuberculosis were between 14 to 560 cells/μl
(mean, 160.85 cells/μl). HIV retinopathy was seen in
6.28% of the patients. Other lesions noted significantly
were acute retinal necrosis in 1.6%, progressive outer
retinal necrosis in (PORN) in 1.17%, syphilis (1.2%),
endophthalmitis (1.02%), fungal corneal ulcer (0.3%),
Figure 1 Composite color fundus photographs showing a case
of active and healed CMV retinitis. Pre- (left) and post-treatment
(right) with ganciclovir.
Figure 3 Color fundus photograph showing a case of active
choroidal granuloma due to tuberculosis.
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(0.73%).
One hundred three patients (15.04%) had anterior seg-
ment, adnexal, and/or ocular surface lesions. CD4 count
range in this subgroup of patients was 19 to 964 cells/
mm3. HZO was the commonest, seen in 21.4% of patients
with anterior segment manifestations (Figure 4). Others
included anterior uveitis in 16 patients (15.57%), ulcerative
blepharitis, keratitis, conjunctival microvasculopathy, kera-
toconjunctivitis, conjunctival squamous cell carcinoma,
molluscum contagiosum, episcleritis, Stevens-Johnson syn-
drome, lid abscess, and herpetic sclerouveitis. Most viral
anterior segment lesions had higher CD4 counts of > 250
cells/mm3. Significantly, 12 patients (13.3%) were not
known to be HIV-positive and were diagnosed based on
clinical suspicion.
Neuro-ophthalmic lesions were seen in 61 patients.
Optic atrophy, seen in 49.45%, and disk edema, seen in
21.97%, were the most prominent manifestations. Others
included optic neuritis in 14.28%, cranial nerve palsies in
9.89%, retrobulbar neuritis in 2.19%, and optic nerve
head infiltration and cortical blindness in one patient
each. Cryptococcus infection was the commonest under-
lying infection in 66% patients.
Multiple ocular opportunistic infections in the same eye/
patient were seen in ten patients. The commonest combin-
ation was presence of toxoplasmic and cytomegalovirus
retinitis, seen in four patients. Others included ocular TB
and CMVR, and herpetic retinitis and CMVR in two
patients each, and ocular toxoplasmosis with ocular syph-
ilis and ocular TB in one patient each.Figure 2 Composite color fundus photographs showing a case
of active (left) and healed (right) toxoplasmic retinochoroiditis.Confirmation of the etiological agent was done in se-
lect cases by intraocular fluid evaluation in 8.6% patients
with a 72% yield. Specific ocular medical and surgical
therapy was administered based on the diagnosis.
The commonest combination regimen of HAART was
lamivudine, nevirapine, and stavudine in 84% of patients.
Drug combinations were individualized based on re-
sponse to treatment or development of resistance under
care of an AIDS care physician.
When comparing patients on antiretroviral therapy
(ART) and those not on ART with respect to the diagno-
sis of ocular lesions, it was found that 52.2% of patients
were on ART at the time of ocular lesion diagnosis, 62%
of them had CD4 < 200 while the rest had CD4 counts
more than 200. While among patients on ART and with-
out ocular lesions, 31% had CD4 counts less than 200,
and significantly, in spite of this, no ocular opportunistic
infection was noted even during the period of follow-up.
There were 47.7% of patients who were not on
HAART at the time of ocular lesion diagnosis; 69% ofFigure 4 External photograph showing herpes zoster
ophthalmicus.
Table 5 Pre- and post-treatment visual acuity:
comparison between various groups based on severity of
visual impairment
Visual acuity Pre-treatment (%) Post-treatment (%)
< 6/12 57.0 58.3
6/12 to 6/60 13.9 13.0
> 6/60 29.1 28.8
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patients not on ART and without ocular lesions, 73% of
patients understandably had CD4 counts more than 200,
while significantly 27% of them had CD4 counts less
than 200 (Table 4).
Immune recovery uveitis (IRU) was seen in 17.4% of the
patients on HAART. Interval between the start of HAART
and onset of IRU was 4 months to 2.5 years, and 52% of
the patients developed IRU when the increase in CD4
counts was between 100 and 150 cells. Seventeen patients
were treated with topical steroids and cycloplegics, one pa-
tient was treated with topical and periocular steroid injec-
tion, and five patients were treated with an additional short
course of oral steroids along with topical steroids.
In our series of patients, immune recovery uveitis was
seen predominantly post-CMVR in 88% of patients, while
IRU post-tuberculous and post-cryptococcal infection was
noted in 6% and 2% of patients with IRU, respectively.
Whereas in 4% of patients, there was inflammation post-
immune recovery; the cause remained undetermined. Re-
currence of ocular infection was seen in 2.53% (post-
HAART) and > 20% (pre-HAART) of patients.
Based on the severity of visual impairment, the patients
were divided into groups with visual acuity better than 6/
12, between 6/12 and 6/60, and worse than 6/60. Pre- and
post-treatment (i.e., at presentation and at final follow-up)
were analyzed (Table 5). At presentation, 57% had visual
acuity better than 6/12, while at final follow-up 58.3% fell in
this group; 13.9% had moderate visual impairment, and at
the end of treatment, 13% were in this group. At presenta-
tion, 29.1% had vision poorer than 6/60, and 28.8%
belonged to this group at the final analysis. The visual out-
come among various groups, pre- and post-treatment, is
given in Table 6.
Considering a two-line improvement in Snellen’s visual
acuity, overall visual outcome showed improvement in
about 14.3% and was maintained in 71.6% of patients.
While in 14.1% of patients, vision deteriorated due to
complications such as retinal detachment, optic atrophy,
macular scarring, and others.
Discussion
India has a large HIV-positive population when com-
pared to many other countries. There have not beenTable 4 Comparison of presence of ocular lesions in
patients with/without HAART in relation to CD4 counts
With ART Without ART
Ocular lesions (%) 52.2 47.8
CD4 < 200 + OI (%) 62 69
No ocular lesions
CD4 < 200 (%) 31 27
CD4 > 200 (%) 69 73many long-term large-scale studies based on HIV-
positive population and ocular lesions in India. In our
published series of first 100 patients, 77% of the HIV-
positive patients were men in the age group of 20 to
40 years; with national figures ranging from 45.6% to
74.2% occurring due to heterosexual transmission [9],
homosexual transmission was only between 5% and 10%
in India. Our study also revealed that ocular involvement
was more common in children who has acquired the
disease due to perinatal transmission (66.7%) and in
homosexual patients (60%). Ocular involvement was com-
paratively less common in patients who had contracted
this disease through blood transfusion (33%) or exposure
to a commercial sex worker (24.3%).
India also has a unique population of undertreated HIV
disease, and they seem to have much lower CD4 counts.
Surprisingly, the opportunistic infections seem to have
many similarities to the West, with very few differences.
Whether long-term exposure to infectious pathogens, or
herd immunity, contributes to the tolerance of Indian eyes
to opportunistic infections is debatable.
The commonest ocular opportunistic infection even in
our study was CMV retinitis as reported in Western lit-
erature [9,10]. The next most common lesion was HIV
retinopathy (6.28%), which is much lesser when com-
pared to studies in Western countries (50%) [8]. In
India, patients infected with HIV do not undergo routine
ophthalmic evaluation. They are often referred for oph-
thalmic examination only if they present with visual
complaints. This fact may result in the underestimation
of asymptomatic HIV retinopathy or early peripheral
CMV retinitis. CMV retinitis was seen even in patients
on HAART. Patients on regular HAART and with
improved CD4 counts, when treated with systemic and/
or intravitreal ganciclovir therapy, showed complete
resolution of retinitis without the need for maintenance
therapy. More importantly, the number of recurrences
was found to be much lesser in such patients, and sys-
temic ganciclovir therapy could be discontinued after
resolution of lesions. The progression of retinitis in
patients on HAART, even with low CD4 counts, was
lesser in Western studies even though they were
expected to behave like pre-HAART-era patients. Al-
though the prognosis was better in most patients on
Table 6 Visual outcome pre- and post-treatment in the various groups
VA outcome Pre-treatment Post-treatment
< 6/12 6/12 to 6/60 > 6/60 < 6/12 6/12 to 6/60 > 6/60
Improved (%) 12.80 26.30 60.90 80.50 12.80 6.80
Maintained (%) 63.40 10.50 26.10 63.30 10.50 26.20
Worsened (%) 68.90 18.90 12.10 10.60 25.80 63.60
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senting with neovascularization, vitreous hemorrhage,
and retinal detachment with proliferative vitreoretinal
changes, as is seen in an immunocompetent state.
In contrast to the study by Jabs et al. [11], in our
study, we found that the progression of retinitis leading
to complications was significantly more in patients with
lower CD4 counts in spite of regular HAART. In an
earlier publication from the same center, low CD4
counts were commonly associated with drug resistance.
Forty six percent of the patients experienced clinical fail-
ure and developed a new WHO-defined opportunistic
infection [12]. We hypothesize that this could be an im-
portant contributing factor for low CD4 counts in spite
of HAART even in our study.
Involvement of the second eye and the occurrence of
retinal detachment in patients who were on regular
HAART have been studied by Jabs et al. [13]. Signifi-
cantly, 88% of the patients with unilateral disease who
were on regular HAART did not have involvement of
the other eye throughout the duration of the follow-up.
Importantly, a CD4 count limit of 200 had a better
clinical correlation with HAART and the occurrence of
ocular lesions, with lesions seen in a larger number of
patients not on HAART and with low CD4 counts.
Interestingly, 27% of the patients were not on HAART
and had persistently low CD4 counts for more than
6 months and did not develop any ocular lesion attribut-
able to HIV.
In the Indian scenario [14], although systemic TB is
the commonest underlying systemic infection, ocular TB
is relatively rare. Ocular TB is found in all CD4 count
ranges, and asymptomatic choroidal tubercles are among
the commonest manifestations of ocular TB in AIDS.
Resolution of systemic and ocular TB with antitubercu-
losis treatment (ATT) is not always concurrent. PCR
and HPE methods have been helpful in diagnosis. Clin-
ical profile with histopathological and microbiological
correlation of ocular tuberculosis in patients with AIDS
has been reported.
Herpetic viral retinitis in our patients on HAART pre-
sented with significant inflammatory reactions, more in
the form of acute retinal necrosis (ARN) than the clas-
sical description of PORN in immunosuppressed indivi-
duals. There were 11 patients with ARN in our study,
much higher than those in the pre-HAART era.Shalaby et al. [15] and Kuo et al. [16] have described
various presentations of syphilis in HIV-positive patients.
Ocular syphilis was found in 1.2% of patients in our
study. Two of our patients were serologically positive for
syphilis and then were diagnosed to be HIV-positive;
suspicion was based on suggestive eye findings and posi-
tive syphilis serology [17]. Both of these patients were
treated with systemic penicillin along with HAART.
Retinal vessel occlusions have been described in
patients with HIV infection [10,17,18]. In our study, we
had two patients (two eyes) with superior temporal
branch retinal vein occlusion and one patient with CMV
retinitis and hemi-central retinal vessel occlusion, all of
whom responded well to anti-CMV treatment.
Steven-Johnson syndrome in HIV-positive patients trea-
ted with nevirapine has been reported [19] and was seen
in our series of patients too. Cryptococcal ocular involve-
ment secondary to intracranial involvement manifesting
as papilledema [20,21], optic atrophy, and ophthalmople-
gias was noted. Though CMVR was the commonest ocu-
lar opportunistic infection even in patients on HAART,
cryptococcal infection and related complications were
more common in gravely ill patients.
In 72% of patients on whom aqueous tap was done, a
confirmed clinical diagnosis could be made based on
aqueous fluid analysis by PCR and/or antibody titers.
The usefulness of AC tap for PCR and antibody produc-
tion has been studied by several authors [22,23]. Though
AIDS-related lymphomas have been reported to have a
better prognosis in the HAART era [24], one patient
with non-Hodgkin’s lymphoma in our study developed
hard palate necrosis and orbital cellulitis with complete
loss of vision.
IRU [25-29] has been extensively studied, and we
have seen it in 17.4% of patients on HAART.
Nguyen et al. [27] have studied the incidence of im-
mune recovery uveitis in 33 patients with CMV ret-
initis, and they found six patients with immune
recovery uveitis. The incidence rate of immune re-
covery uveitis was 0.109/person-year in their study.
Kempen et al. [28] concluded that patients with IRU have
a higher risk of additional morbidity over and above that
seen in patients with CMV retinitis. Similar findings were
noted in our series of patients. Immune recovery state had
led to differences in the way the ocular lesions presented
along with drug-induced reactions.
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CMV retinitis is still the leading cause of ocular oppor-
tunistic infection in India, and ocular toxoplasmosis is
the second commonest. Although HAART reduced the
risk of OIs, newer manifestations of known diseases such
as in CMV and neovascularization or retinal detachment
and newer ocular lesions such as drug-related reactions
are being seen in patients on HAART. Ocular opportun-
istic infections may present with significant inflamma-
tory reaction in patients on HAART. Ocular TB is
common in India although not proportional to systemic
TB in the Indian HIV-positive population. Paradoxical
worsening post-TB infection is also noted in patients on
HAART and ATT.
Even in comparison with the previous study in India
[9], other opportunistic infections such as ocular toxo-
plasmosis, ocular tuberculosis, and HZO were found in
large numbers in the present study. It could perhaps be
due to the increased awareness and referral by physi-
cians in India. This also indicates the need for regular
ophthalmic evaluation of all patients with HIV/AIDS ir-
respective of CD4 counts as ocular lesions are noted in
spite of HAART.
Treatment options need to be modified based on local
needs and resource constraint settings such as the use of
intravitreal ganciclovir. In contrast to Western studies,
in our patients on HAART, ocular lesions do not always
behaved as in immunocompetent individuals. Ocular TB
needs to be kept in mind in India, as well as other
neuro-ophthalmic manifestations related to cryptococci,
especially in gravely ill patients. Interestingly in India,
even with incomplete or irregular HAART, the occur-
rence of opportunistic infections did not vary much
when compared to many other Western studies.
Early recognition and treatment of vision-threatening
ocular opportunistic infection and IRU can lead to main-
tenance/improvement of visual acuity in most patients.
Importantly, our study included patients spanning the
pre- and post-HAART era with a regular ocular and sys-
temic follow-up using a standard protocol at both the
tertiary care eye center and the AIDS care center. Al-
though there are a few limitations as in any long-
duration study due to changes in the disease pattern,
which have also been studied, our study has shown that
the occurrence and frequency of various ocular oppor-
tunistic infections in developing nations such as India
has significant variations from those reported in West-
ern literature and need to be managed accordingly.
Methods
The first 1,000 consecutive patients found to be HIV-
positive who were seen in the outpatient department of
a tertiary eye care institute in India between December
1993 and June 2010 were analyzed. All patientsdiagnosed with HIV infection who were either referred
to the institute for evaluation of their visual complaints
or with low CD4 counts/advanced systemic disease were
included. Patients with a minimal follow-up of 3 months
and/or with at least two follow-up visits to both the oph-
thalmic clinic and the AIDS care center were the inclu-
sion criteria. Other patients presenting to our clinic who
were not originally known to be HIV-positive and were
subsequently tested for and diagnosed to be HIV-
positive because of suspicious ocular lesions were also
included. Complete ophthalmic evaluation findings in-
cluding thorough history, best corrected visual acuity,
external eye examination, clinical features, and fundus
evaluation by indirect ophthalmoscopy were analyzed.
Fundus fluorescein angiography, ultrasound examin-
ation, ultrasound biomicroscopy, and other ancillary
investigations such as electroretinogram and optical co-
herence tomography were obtained in all cases wherever
necessary. All these patients had a thorough systemic
evaluation at an AIDS care and research center in the
city. All patients in our series were screened for asso-
ciated opportunistic systemic infections such as tubercu-
losis, syphilis, toxoplasmosis, cryptococcal infection, etc.
along with routine blood investigations. Information was
recorded in a precoded proforma. CD4+ and CD8+
counts were obtained in all cases at the time of inclusion
into the study. The antiretroviral drugs used for the
treatment of AIDS and their effect on the disease and on
the eye were also analyzed. Lab investigations related to
ocular and systemic findings were also analyzed in
detail.
Study design
A prospective observational case series design was used
in this study.
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